What are the recommended dosing regimens, contraindications, and common adverse effects of tadalafil (phosphodiesterase‑5 inhibitor) for erectile dysfunction in adult men?

Tadalafil for Erectile Dysfunction: Dosing, Contraindications, and Adverse Effects

For erectile dysfunction, start tadalafil at 10 mg taken as needed 30 minutes before sexual activity, or use 2.5–5 mg once daily for spontaneous sexual activity; both regimens significantly improve erectile function with a favorable safety profile, but tadalafil is absolutely contraindicated with any nitrate use due to potentially fatal hypotension. 1, 2

Recommended Dosing Regimens

As-Needed Dosing

• Start with 10 mg taken at least 30 minutes before anticipated sexual activity, with efficacy lasting up to 36 hours 2, 1
• Titrate to 20 mg if response is inadequate after at least 5 attempts, or reduce to 5 mg if side effects occur 2, 1
• Maximum dosing frequency is once per day 2
• Unlike sildenafil and vardenafil, tadalafil does NOT show dose-dependent efficacy between 5 mg, 10 mg, and 20 mg—choose between 10 mg and 20 mg based primarily on tolerability rather than expecting dramatically better efficacy at higher doses 1

Once-Daily Dosing

• Start with 2.5 mg taken at approximately the same time every day, without regard to timing of sexual activity 2, 1
• Increase to 5 mg daily based on individual efficacy and tolerability 2
• This regimen eliminates the need to time medication with sexual activity, providing an alternative for couples who prefer spontaneous rather than scheduled sexual encounters 1

Dual Indication (ED + BPH)

• Tadalafil 5 mg once daily is FDA-approved to treat both erectile dysfunction and benign prostatic hyperplasia simultaneously 1, 2
• This represents a unique advantage when both conditions coexist 3, 4

Absolute Contraindications

Nitrate Use (Most Critical)

• Concurrent use of any nitrate medication—including sublingual nitroglycerin, long-acting nitrates, isosorbide dinitrate, or recreational "poppers"—is absolutely contraindicated due to risk of potentially fatal hypotension 1, 2
• If emergency nitrate administration is required, wait at least 48 hours after tadalafil use (compared to 24 hours for sildenafil), under close medical supervision with continuous monitoring 1

Guanylate Cyclase Stimulators

• Co-administration with riociguat is contraindicated because it can cause severe hypotension 1

High-Risk Cardiovascular Conditions

Defer tadalafil treatment until cardiac condition is stabilized in patients with: 5, 1

• Unstable or refractory angina
• Uncontrolled hypertension
• Recent myocardial infarction or stroke (within 2 weeks)
• NYHA Class II or higher heart failure
• High-risk arrhythmias
• Hypertrophic obstructive cardiomyopathy
• Moderate-to-severe valvular disease

Other Contraindications

• Severe hepatic impairment (Child-Pugh Class C) 2
• Previous sudden vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION) after PDE5 inhibitor use 5, 2

Cardiovascular Risk Stratification Before Prescribing

Low-Risk Patients (Safe to Prescribe)

Verify the patient can walk 1 mile in 20 minutes or climb 2 flights of stairs without symptoms before prescribing 5, 1

Low-risk criteria include: 1

• Asymptomatic coronary artery disease with <3 risk factors
• Controlled hypertension
• Mild, stable angina
• Successful coronary revascularization
• Uncomplicated prior myocardial infarction
• Mild valvular disease
• CHF (NYHA Class I)

Indeterminate Risk

Refer to cardiology before prescribing if the patient cannot perform moderate physical activity or cardiovascular risk is unclear 1

Common Adverse Effects

Most Frequent Side Effects

The most common adverse events are mild to moderate and include: 1, 2

• Dyspepsia (most common)
• Headache
• Back pain (more common with tadalafil than other PDE5 inhibitors)
• Myalgia
• Nasal congestion
• Flushing (lower rates compared to sildenafil) 1

Serious Adverse Events (Rare)

Priapism

• Erections lasting >4 hours require emergency medical attention to prevent irreversible erectile tissue damage 2

Sudden Vision Loss

• Stop tadalafil immediately and seek medical attention if sudden vision loss occurs in one or both eyes—may indicate NAION 2
• Risk is increased in patients with prior NAION in one eye 2

Sudden Hearing Loss

• Stop tadalafil and seek prompt medical attention if sudden hearing decrease or loss occurs, which may be accompanied by tinnitus and dizziness 2

Dose Adjustments in Special Populations

Renal Impairment (As-Needed Dosing)

• Creatinine clearance 30–50 mL/min: Start with 5 mg, maximum 10 mg once every 48 hours 2
• Creatinine clearance <30 mL/min or hemodialysis: Maximum 5 mg once every 72 hours 2

Renal Impairment (Once-Daily Dosing)

• Creatinine clearance 30–50 mL/min: Start with 2.5 mg, may increase to 5 mg 2
• Creatinine clearance <30 mL/min or hemodialysis: Once-daily dosing not recommended 2

Hepatic Impairment

• Mild-to-moderate (Child-Pugh A or B): Maximum 10 mg once daily for as-needed dosing; use caution with once-daily dosing 2
• Severe (Child-Pugh C): Not recommended 2

Concomitant CYP3A4 Inhibitors

• With potent CYP3A4 inhibitors (ketoconazole, ritonavir): Maximum 10 mg once every 72 hours for as-needed dosing, or maximum 2.5 mg for once-daily dosing 2

Critical Factors for Treatment Success

Defining an Adequate Trial

Before declaring treatment failure, ensure at least 5 separate attempts at maximum tolerated dose with proper technique 1

Modifiable Factors to Address

Many apparent failures result from correctable issues: 1

• Sexual stimulation is mandatory—tadalafil enhances but does not replace natural arousal 1, 2
• Avoid taking with large or fatty meals (though less affected than sildenafil) 1
• Limit heavy alcohol consumption—both tadalafil and alcohol are vasodilators, increasing risk of orthostatic hypotension 2
• Evaluate for testosterone deficiency—men with low testosterone (<300 ng/dL) respond less robustly to PDE5 inhibitors alone 1
• Screen for relationship issues, depression, or anxiety 1

Special Populations with Lower Response Rates

Men with diabetes and post-prostatectomy patients have more severe baseline ED and may respond less robustly, though tadalafil remains significantly superior to placebo in these groups 1

Combination Therapy Considerations

Testosterone Deficiency

For men with ED and testosterone deficiency, combining tadalafil with testosterone therapy is more effective than tadalafil alone 1

Alpha-Blockers

• For ED: Patients should be stable on alpha-blocker therapy before initiating tadalafil at the lowest dose 2
• For BPH: Tadalafil is not recommended in combination with alpha-blockers for BPH treatment 2

Alcohol Interaction Warning

Substantial alcohol consumption (≥5 units) combined with tadalafil increases the potential for orthostatic signs and symptoms, including increased heart rate, decreased standing blood pressure, dizziness, and headache 2

Common Pitfalls to Avoid

• Declaring treatment failure without completing at least 5 attempts at maximum dose with proper technique 1
• Failing to verify absence of nitrate use in all forms, including recreational "poppers" 1
• Not assessing cardiovascular fitness before prescribing—patients unable to perform moderate physical activity require cardiology referral 1
• Ignoring testosterone deficiency—check testosterone levels if response is suboptimal 1
• Prescribing without adequate sexual stimulation counseling—the drug requires arousal to work 1, 2